{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:05:27Z","timestamp":1793919927369,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","award":["R353-A20584"],"award-info":[{"award-number":["R353-A20584"]}],"id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005940","name":"Dansk Kr\u00e6ftforsknings Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005940","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007420","name":"L\u00e6geforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007420","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Overl\u00e6ger\u00e5dets forskningsfond"},{"DOI":"10.13039\/100007403","name":"Dagmar Marshalls Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007403","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014553","name":"Simon Spies Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010346","name":"Else og Mogens Wedell Wedellsborgs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010346","id-type":"DOI","asserted-by":"publisher"}]},{"name":"T\u00f8mrerhandler Vilhelm Bangs fond"},{"DOI":"10.13039\/501100006356","name":"University of Southern Denmark","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"DOI":"10.1186\/s13063-025-08829-3","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T02:41:33Z","timestamp":1744080093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Topical tacrolimus for the amelioration of breast cancer-related lymphedema (TACLE Trial): a study protocol for a randomized, double-blind, placebo-controlled phase II\/III trial"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4588-8053","authenticated-orcid":false,"given":"Frederik Gulmark","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads Gustaf","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rn Bo","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Ahm","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"issue":"6","key":"8829_CR1","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/S1470-2045(13)70076-7","volume":"14","author":"T DiSipio","year":"2013","unstructured":"DiSipio T, Rye S, Newman B, Hayes S. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500\u201315.","journal-title":"Lancet Oncol"},{"issue":"2","key":"8829_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jso.25944","volume":"122","author":"CL Brunelle","year":"2020","unstructured":"Brunelle CL, Roberts SA, Shui AM, Gillespie TC, Daniell KM, Naoum GE, et al. Patients who report cording after breast cancer surgery are at higher risk of lymphedema: results from a large prospective screening cohort. J Surg Oncol. 2020;122(2):155\u201363.","journal-title":"J Surg Oncol"},{"issue":"1","key":"8829_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3322\/caac.20001","volume":"59","author":"BD Lawenda","year":"2009","unstructured":"Lawenda BD, Mondry TE, Johnstone PA. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment. CA Cancer J Clin. 2009;59(1):8\u201324.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"8829_CR4","first-page":"3","volume":"53","author":"Executive Committee of the International Society of L","year":"2020","unstructured":"Executive Committee of the International Society of L. The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the International Society of Lymphology. Lymphology. 2020;53(1):3\u201319.","journal-title":"Lymphology"},{"issue":"20","key":"8829_CR5","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1200\/JCO.19.02896","volume":"38","author":"SA McLaughlin","year":"2020","unstructured":"McLaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol. 2020;38(20):2341\u201350.","journal-title":"J Clin Oncol"},{"issue":"1","key":"8829_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41416-020-0844-4","volume":"123","author":"N Bundred","year":"2020","unstructured":"Bundred N, Foden P, Todd C, Morris J, Watterson D, Purushotham A, et al. Increases in arm volume predict lymphoedema and quality of life deficits after axillary surgery: a prospective cohort study. Br J Cancer. 2020;123(1):17\u201325.","journal-title":"Br J Cancer"},{"issue":"2","key":"8829_CR7","first-page":"CD011433","volume":"2","author":"SP Markkula","year":"2019","unstructured":"Markkula SP, Leung N, Allen VB, Furniss D. Surgical interventions for the prevention or treatment of lymphoedema after breast cancer treatment. Cochrane Database Syst Rev. 2019;2(2):CD011433.","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"8829_CR8","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jid.2015.12.001","volume":"136","author":"F Ogata","year":"2016","unstructured":"Ogata F, Fujiu K, Matsumoto S, Nakayama Y, Shibata M, Oike Y, et al. Excess lymphangiogenesis cooperatively induced by macrophages and CD4(+) T cells drives the pathogenesis of lymphedema. J Invest Dermatol. 2016;136(3):706\u201314.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"8829_CR9","doi-asserted-by":"publisher","first-page":"H1065","DOI":"10.1152\/ajpheart.00598.2014","volume":"308","author":"S Ghanta","year":"2015","unstructured":"Ghanta S, Cuzzone DA, Torrisi JS, Albano NJ, Joseph WJ, Savetsky IL, et al. Regulation of inflammation and fibrosis by macrophages in lymphedema. Am J Physiol Heart Circ Physiol. 2015;308(9):H1065\u201377.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3","key":"8829_CR10","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1096\/fj.12-222695","volume":"27","author":"T Avraham","year":"2013","unstructured":"Avraham T, Zampell JC, Yan A, Elhadad S, Weitman ES, Rockson SG, et al. Th2 differentiation is necessary for soft tissue fibrosis and lymphatic dysfunction resulting from lymphedema. FASEB J. 2013;27(3):1114\u201326.","journal-title":"FASEB J"},{"issue":"11","key":"8829_CR11","doi-asserted-by":"publisher","first-page":"e49940","DOI":"10.1371\/journal.pone.0049940","volume":"7","author":"JC Zampell","year":"2012","unstructured":"Zampell JC, Yan A, Elhadad S, Avraham T, Weitman E, Mehrara BJ. CD4(+) cells regulate fibrosis and lymphangiogenesis in response to lymphatic fluid stasis. PLoS ONE. 2012;7(11):e49940.","journal-title":"PLoS ONE"},{"key":"8829_CR12","first-page":"CD009864","volume":"7","author":"J Cury Martins","year":"2015","unstructured":"Cury Martins J, Martins C, Aoki V, Gois AF, Ishii HA, da Silva EM. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev. 2015;7:CD009864.","journal-title":"Cochrane Database Syst Rev"},{"key":"8829_CR13","first-page":"153","volume":"6","author":"N Malecic","year":"2016","unstructured":"Malecic N, Young H. Tacrolimus for the management of psoriasis: clinical utility and place in therapy. Psoriasis (Auckl). 2016;6:153\u201363.","journal-title":"Psoriasis (Auckl)"},{"issue":"7","key":"8829_CR14","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jid.2020.12.028","volume":"141","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, et al. Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study. J Invest Dermatol. 2021;141(7):1728\u201334.","journal-title":"J Invest Dermatol."},{"issue":"2","key":"8829_CR15","doi-asserted-by":"publisher","first-page":"e31465","DOI":"10.1371\/journal.pone.0031465","volume":"7","author":"K Tsuda","year":"2012","unstructured":"Tsuda K, Yamanaka K, Kitagawa H, Akeda T, Naka M, Niwa K, et al. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of naive T cells into cytokine-producing mature T cells. PLoS ONE. 2012;7(2):e31465.","journal-title":"PLoS ONE"},{"key":"8829_CR16","doi-asserted-by":"publisher","first-page":"14345","DOI":"10.1038\/ncomms14345","volume":"8","author":"JC Gardenier","year":"2017","unstructured":"Gardenier JC, Kataru RP, Hespe GE, Savetsky IL, Torrisi JS, Nores GD, et al. Topical tacrolimus for the treatment of secondary lymphedema. Nat Commun. 2017;8:14345.","journal-title":"Nat Commun"},{"key":"8829_CR17","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4048\/jbc.2023.26.e2","volume":"26","author":"FC Gulmark Hansen","year":"2023","unstructured":"Gulmark Hansen FC, J\u00f8rgensen MG, S\u00f8rensen JA. Treatment of breast cancer-related lymphedema with topical tacrolimus: a prospective, open-label, single-arm, phase II pilot trial. J Breast Cancer. 2023;26:26.","journal-title":"J Breast Cancer"},{"issue":"1","key":"8829_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41523-021-00276-y","volume":"7","author":"MG Jorgensen","year":"2021","unstructured":"Jorgensen MG, Toyserkani NM, Hansen FG, Bygum A, Sorensen JA. The impact of lymphedema on health-related quality of life up to 10 years after breast cancer treatment. NPJ Breast Cancer. 2021;7(1):70.","journal-title":"NPJ Breast Cancer"},{"issue":"6","key":"8829_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3109\/2000656X.2012.714785","volume":"46","author":"H Brorson","year":"2012","unstructured":"Brorson H, Hoijer P. Standardised measurements used to order compression garments can be used to calculate arm volumes to evaluate lymphoedema treatment. J Plast Surg Hand Surg. 2012;46(6):410\u20135.","journal-title":"J Plast Surg Hand Surg"},{"issue":"2","key":"8829_CR20","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11136-014-0785-6","volume":"24","author":"C Treanor","year":"2015","unstructured":"Treanor C, Donnelly M. A methodological review of the Short Form Health Survey 36 (SF-36) and its derivatives among breast cancer survivors. Qual Life Res. 2015;24(2):339\u201362.","journal-title":"Qual Life Res"},{"issue":"2","key":"8829_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.5535\/arm.2012.36.2.240","volume":"36","author":"JE Park","year":"2012","unstructured":"Park JE, Jang HJ, Seo KS. Quality of life, upper extremity function and the effect of lymphedema treatment in breast cancer related lymphedema patients. Ann Rehabil Med. 2012;36(2):240\u20137.","journal-title":"Ann Rehabil Med"},{"issue":"9","key":"8829_CR22","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1245\/s10434-021-09887-y","volume":"28","author":"AF Klassen","year":"2021","unstructured":"Klassen AF, Tsangaris E, Kaur MN, Poulsen L, Beelen LM, Jacobsen AL, et al. Development and psychometric validation of a patient-reported outcome measure for arm lymphedema: the LYMPH-Q upper extremity module. Ann Surg Oncol. 2021;28(9):5166\u201382.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"8829_CR23","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00238-021-01890-6","volume":"45","author":"CB Madsen","year":"2022","unstructured":"Madsen CB, Poulsen L, J\u00f8rgensen MG, Lorenzen MM, Tsangaris E, Klassen A, et al. Advanced translation and cultural adaption of the LYMPH-Q upper extremity module from English to Danish. Eur J Plast Surg. 2022;45(4):617\u201322.","journal-title":"Eur J Plast Surg"},{"issue":"4","key":"8829_CR24","first-page":"184","volume":"46","author":"C Shah","year":"2013","unstructured":"Shah C, Vicini F, Beitsch P, Laidley A, Anglin B, Ridner SH, et al. The use of bioimpedance spectroscopy to monitor therapeutic intervention in patients treated for breast cancer related lymphedema. Lymphology. 2013;46(4):184\u201392.","journal-title":"Lymphology"},{"issue":"2","key":"8829_CR25","first-page":"85","volume":"46","author":"MR Fu","year":"2013","unstructured":"Fu MR, Cleland CM, Guth AA, Kayal M, Haber J, Cartwright F, et al. L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity. Lymphology. 2013;46(2):85\u201396.","journal-title":"Lymphology"},{"key":"8829_CR26","doi-asserted-by":"publisher","unstructured":"J\u00f8rgensen MG, Toyserkani NM, Hansen FCG, Thomsen JB, S\u00f8rensen JA. Prospective Validation of Indocyanine Green Lymphangiography Staging of Breast Cancer-Related Lymphedema. Cancers (Basel). 2021;13(7):1540. https:\/\/doi.org\/10.3390\/cancers13071540.","DOI":"10.3390\/cancers13071540"},{"issue":"1","key":"8829_CR27","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1089\/lrb.2016.0029","volume":"15","author":"D Sun","year":"2017","unstructured":"Sun D, Yu Z, Chen J, Wang L, Han L, Liu N. The value of using a SkinFibroMeter for diagnosis and assessment of secondary lymphedema and associated fibrosis of lower limb skin. Lymphat Res Biol. 2017;15(1):70\u20136.","journal-title":"Lymphat Res Biol"},{"key":"8829_CR28","unstructured":"Sealed Envelope Ltd. 2024. Simple randomisation service. [Online] Available from:\nhttps:\/\/www.sealedenvelope.com\/simple-randomiser\/v1\/. Accessed 5 Apr 2025."},{"issue":"7","key":"8829_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41393-018-0169-9","volume":"56","author":"LA Harvey","year":"2018","unstructured":"Harvey LA. REDCap: web-based software for all types of data storage and collection. Spinal Cord. 2018;56(7):625.","journal-title":"Spinal Cord"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-08829-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-08829-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:12:31Z","timestamp":1744204351000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-08829-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8829"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-08829-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4943015\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"27 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by The Danish Medicines Agency and the Medical Research Ethics Committees (MREC) through the Clinical Trials Information System (CTIS). The committee\u2019s reference number for this approval is EU CT Number: 2023 -\u2009503644 -\u200913 -\u200900. Written, informed consent to participate will be obtained from all participants prior to any study-related procedures.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Consent form in Danish.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"127"}}